Drug Combo a 'Milestone' in Treating Pre-Cancerous Smoldering Myeloma Researchers Finding Drug Combo a 'Milestone' in Treating Pre-Cancerous Smoldering MyelomaSylvester Researchers Finding Drug Combo a 'Milestone' in Treating Pre-Cancerous Smoldering Myeloma
In a study published in JAMA Oncology, researchers at the Sylvester Comprehensive Cancer Center in the University of Miami’s Miller School of Medicine, the National Cancer Institute and other research institutes showed that a three-drug combination (carfilzomib, lenalidomide and dexamethasone, followed by lenalidomide maintenance therapy) prevented smoldering myeloma patients from progressing to multiple myeloma. Approximately 70% of patients showed no minimal residual disease a median 5 1/2 years after treatment.
This seems like it would be an amazing advance. If we can nip smoldering myeloma (and I would presume smoldering Wallys) in the bud before it ever gets to cancer.. this could massively increase survival times. On this study alone, adding 5 and 1/2 years to any myeloma patients life is a massive gift.
